These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 16755414)

  • 1. [Difficulties in the diagnosis and treatment of major depressive disorder with comorbid anxiety symptoms].
    Akkaya C
    Turk Psikiyatri Derg; 2006; 17(2):139-46. PubMed ID: 16755414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of nefazodone augmentation for treatment-resistant depression with anxiety symptoms or anxiety disorder.
    Taylor FB; Prather MR
    Depress Anxiety; 2003; 18(2):83-8. PubMed ID: 12964175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major depressive disorder: remission of associated symptoms.
    Trivedi MH
    J Clin Psychiatry; 2006; 67 Suppl 6():27-32. PubMed ID: 16848674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome.
    Howland RH; Rush AJ; Wisniewski SR; Trivedi MH; Warden D; Fava M; Davis LL; Balasubramani GK; McGrath PJ; Berman SR
    Drug Alcohol Depend; 2009 Jan; 99(1-3):248-60. PubMed ID: 18986774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The acute treatment of anxiety and depression.
    Swinson RP
    Psychiatr J Univ Ott; 1989 Jun; 14(2):375-8; discussion 379-80. PubMed ID: 2569748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding and treating depression in anxious patients.
    Dubovsky SL
    J Clin Psychiatry; 1990 Oct; 51 Suppl():3-8; discussion 14-7. PubMed ID: 1976623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling the diagnostic clues of depression and GAD: the primary care challenge.
    den Boer JA; Evans DL; Lee S; Salin-Pascual R
    Psychopharmacol Bull; 2002; 36 Suppl 2():150-7. PubMed ID: 12490831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual anxiety symptoms in depressed primary care patients.
    McIntyre RS; Konarski JZ; Soczynska JK; Kennedy SH
    J Psychiatr Pract; 2007 Mar; 13(2):125-8. PubMed ID: 17414691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duloxetine in the treatment of major psychiatric and neuropathic disorders.
    Müller N; Schennach R; Riedel M; Möller HJ
    Expert Rev Neurother; 2008 Apr; 8(4):527-36. PubMed ID: 18416656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of pain on outcomes in a trial of duloxetine treatment of major depressive disorder.
    Arnold LM; Meyers AL; Sunderajan P; Montano CB; Kass E; Trivedi M; Wohlreich MM
    Ann Clin Psychiatry; 2008; 20(4):187-93. PubMed ID: 19034749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary management of comorbid anxiety and depression in geriatric patients.
    Doraiswamy PM
    J Clin Psychiatry; 2001; 62 Suppl 12():30-5. PubMed ID: 11430616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptoms of anxiety in depression: assessment of item performance of the Hamilton Anxiety Rating Scale in patients with depression.
    Vaccarino AL; Evans KR; Sills TL; Kalali AH
    Depress Anxiety; 2008; 25(12):1006-13. PubMed ID: 18800370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological approaches to the treatment of residual symptoms.
    Fava M
    J Psychopharmacol; 2006 May; 20(3 Suppl):29-34. PubMed ID: 16644769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting treatment in patients with mixed symptoms of anxiety and depression.
    Fawcett J
    J Clin Psychiatry; 1990 Nov; 51 Suppl():40-3. PubMed ID: 1977742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in antidepressant therapy in special populations.
    Hayes D
    Am J Manag Care; 2004 Jul; 10(6 Suppl):S179-85. PubMed ID: 15354675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human cost of not achieving full remission in depression.
    McIntyre RS; O'Donovan C
    Can J Psychiatry; 2004 Mar; 49(3 Suppl 1):10S-16S. PubMed ID: 15147032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating depression in the medically ill.
    Iosifescu DV
    Psychiatr Clin North Am; 2007 Mar; 30(1):77-90. PubMed ID: 17362805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major depressive disorder: psychosocial impairment and key considerations in functional improvement.
    Papakostas GI
    Am J Manag Care; 2009 Dec; 15(11 Suppl):S316-21. PubMed ID: 20088627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. St. John's wort and Kava in treating major depressive disorder with comorbid anxiety: a randomised double-blind placebo-controlled pilot trial.
    Sarris J; Kavanagh DJ; Deed G; Bone KM
    Hum Psychopharmacol; 2009 Jan; 24(1):41-8. PubMed ID: 19090505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression.
    Trivedi MH; Lin EH; Katon WJ
    CNS Spectr; 2007 Aug; 12(8 Suppl 13):1-27. PubMed ID: 17986951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.